Kim, J.H.; Kang, S.H.; Lee, M.; Youn, G.S.; Kim, T.S.; Jun, B.G.; Kim, M.Y.; Kim, Y.D.; Cheon, G.J.; Kim, D.J.;
et al. Serum Myostatin Predicts the Risk of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis: A Multicenter Study. Cancers 2020, 12, 3347.
https://doi.org/10.3390/cancers12113347
AMA Style
Kim JH, Kang SH, Lee M, Youn GS, Kim TS, Jun BG, Kim MY, Kim YD, Cheon GJ, Kim DJ,
et al. Serum Myostatin Predicts the Risk of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis: A Multicenter Study. Cancers. 2020; 12(11):3347.
https://doi.org/10.3390/cancers12113347
Chicago/Turabian Style
Kim, Ji Hyun, Seong Hee Kang, Minjong Lee, Gi Soo Youn, Tae Suk Kim, Baek Gyu Jun, Moon Young Kim, Young Don Kim, Gab Jin Cheon, Dong Joon Kim,
and et al. 2020. "Serum Myostatin Predicts the Risk of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis: A Multicenter Study" Cancers 12, no. 11: 3347.
https://doi.org/10.3390/cancers12113347
APA Style
Kim, J. H., Kang, S. H., Lee, M., Youn, G. S., Kim, T. S., Jun, B. G., Kim, M. Y., Kim, Y. D., Cheon, G. J., Kim, D. J., Baik, S. K., Choi, D. H., & Suk, K. T.
(2020). Serum Myostatin Predicts the Risk of Hepatocellular Carcinoma in Patients with Alcoholic Cirrhosis: A Multicenter Study. Cancers, 12(11), 3347.
https://doi.org/10.3390/cancers12113347